Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

KOL Strategy

- PMLiVE

Diversity and inclusion

It may not be something we can change overnight, but it is certainly something we need to start to address now

- PMLiVE

Phase 1/2a results for J&J’s COVID-19 vaccine show early promise

Vaccine produced neutralising antibodies in 98% of participants

AstraZeneca AZ

EU will shoulder certain liability costs in AZ COVID-19 vaccine deal

Low-cost deal will see the EU assume responsibility for side-effect claims

The concordance conundrum: the tech divide

COVID-19 resulted in the rapid adoption of virtual consultations; while they offer increased accessibility and convenience for some, are they really all they are cracked up to be? Consultations in...

Page & Page Health

- PMLiVE

J&J advances COVID-19 vaccine into phase 3 testing

News comes after last week's announcement from Novavax on its launch of a UK-based phase 3 trial

- PMLiVE

Q&A: Isabel Gibson

PME interviews W2O ISO's Managing Director

- PMLiVE

Pearls of wisdom

The Americas have been ravaged by COVID-19 – here are some important lessons we have learned

- PMLiVE

Novavax starts first phase 3 COVID-19 vaccine trial in the UK

Trial is set to enrol up to 10,000 participants aged 18-84

- PMLiVE

Lilly’s Verzenio scores a win in early-stage breast cancer

Positive data was presented at 2020 ESMO virtual congress

- PMLiVE

FDA sets January decision date for Xalkori in ALK-positive lymphoma

FDA submission is based on results from ADVL0912 and A8081013 studies

Using Artificial Intelligence to Transform Pharma

Dr. Andree Bates, Founder & CEO of Eularis, discusses how Eularis helps healthcare teams utilize AI and “Future Tech” to solve their biggest commercial challenges and deliver measurable growth. Among many...

Impetus Digital

Session 4: Systems Innovation Insight and Thinking

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links